These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Cutbacks threaten HIV gains. Wadman M Nature; 2011 Dec; 480(7376):159-60. PubMed ID: 22158216 [No Abstract] [Full Text] [Related]
24. Questions, questions. The future of HIV research. Huff B GMHC Treat Issues; 2005 Dec; 19(12):4-8. PubMed ID: 16909507 [No Abstract] [Full Text] [Related]
25. Biomedical research gets a fresh twist down on the farm. Russo G Nature; 2006 Sep; 443(7108):128-9. PubMed ID: 16971913 [No Abstract] [Full Text] [Related]
27. A single case of multidrug-resistant HIV and rapid disease progression. O'Rourke M AIDS Clin Care; 2005 Mar; 17(3):21-2. PubMed ID: 15828115 [No Abstract] [Full Text] [Related]
28. RAND/Hartford initiative to build interdisciplinary geriatric health care research centers. Pincus HA; Keyser DJ; Schultz DJ Health Aff (Millwood); 2007; 26(1):279-83. PubMed ID: 17211038 [TBL] [Abstract][Full Text] [Related]
29. Wellcome Trust makes it personal in funding revamp. Gilbert N Nature; 2009 Nov; 462(7270):145. PubMed ID: 19907461 [No Abstract] [Full Text] [Related]
30. Use of NIH funds placed under a spotlight. Marris E Nature; 2005 Sep; 437(7059):601. PubMed ID: 16193003 [No Abstract] [Full Text] [Related]
31. [Various triple therapies in direct comparison. New decision aids for initial therapy]. MMW Fortschr Med; 2000 Mar; 142 Suppl 1():40-2. PubMed ID: 10863309 [No Abstract] [Full Text] [Related]
32. Understanding the principles of anti-HIV drug therapy. Horn T Surviv News (Atlanta Ga); 2001 Jul; ():13. PubMed ID: 11683014 [No Abstract] [Full Text] [Related]
33. Trial suggests vaccines could aid HIV therapy. Check E Nature; 2003 Apr; 422(6933):650. PubMed ID: 12700722 [No Abstract] [Full Text] [Related]
34. Update of the drug resistance mutations in HIV-1: 2004. Johnson VA; Brun-Vézinet F; Clotet B; Conway B; D'Aquila RT; Demeter LM; Kuritzkes DR; Pillay D; Schapiro JM; Telenti A; Richman DD Top HIV Med; 2004; 12(4):119-24. PubMed ID: 15516709 [No Abstract] [Full Text] [Related]
35. Can treatment during primary HIV infection lead to control of disease without drugs? Gegeny T Res Initiat Treat Action; 2002; 7(2):11-4. PubMed ID: 11965922 [TBL] [Abstract][Full Text] [Related]
36. Correlates of cytotoxic T-lymphocyte-mediated virus control: implications for immunosuppressive infections and their treatment. Wodarz D; Nowak MA Philos Trans R Soc Lond B Biol Sci; 2000 Aug; 355(1400):1059-70. PubMed ID: 11186307 [TBL] [Abstract][Full Text] [Related]
37. Re-emergence of HIV after stopping therapy. Chun TW; Davey RT; Engel D; Lane HC; Fauci AS Nature; 1999 Oct; 401(6756):874-5. PubMed ID: 10553903 [No Abstract] [Full Text] [Related]
38. [Effects of double and triple antiretroviral agents on the HCV viral load in patients coinfected with HIV and HCV]. Gavazzi G; Richallet G; Morand P; Bouchard O; Bosseray A; Leclercq P; Micoud M Pathol Biol (Paris); 1998 Jun; 46(6):412-5. PubMed ID: 9769871 [TBL] [Abstract][Full Text] [Related]
39. Universities and the money fix. Martinson BC Nature; 2007 Sep; 449(7159):141-2. PubMed ID: 17851495 [No Abstract] [Full Text] [Related]
40. Early success claimed for Zerhouni's NIH roadmap. Wadman M Nature; 2004 Oct; 431(7011):886. PubMed ID: 15496879 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]